Omeros Corporation (OMER) is a publicly traded Healthcare sector company. As of May 21, 2026, OMER trades at $12.43 with a market cap of $846.79M and a P/E ratio of 9.45. OMER moved +3.43% today. Year to date, OMER is -19.61%; over the trailing twelve months it is +276.29%. Its 52-week range spans $2.95 to $17.65. Analyst consensus is buy with an average price target of $40.00. Rallies surfaces OMER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes OMER SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $12.43 |
| Market Cap | $846.79M |
| P/E Ratio | 9.45 |
| EPS | $1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.65 |
| 52-Week Low | $2.95 |
| Volume | 984 |
| Avg Volume | 0 |
| Revenue (TTM) | $9.89M |
| Net Income | $86.17M |
| Gross Margin | 0.00% |
2 analysts cover OMER: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $40.00.